Is anybody considering switching your SBRT prescription to 34 Gy in 1 fraction, given preliminary results of RTOG 0915?
Is there a more recent update than the ASTRO Atlanta? I remember the control rates and toxicity were equivalent with 1 year follow-up, so if there's something more recent I'm assuming it's with 2 years follow-up (I couldn't find anything with a quick search, so if have a link please post if you can). Even still, we should be "curing" a fair amount of early stage lung cancer so I would need pretty compelling superiority rather than equivalence to switch - would still worry about late toxicity personally. Some would argue we still don't fully know the late toxicity even with the 4 fraction approach..